Format

Send to

Choose Destination
Curr Cardiol Rep. 2015 Dec;17(12):120. doi: 10.1007/s11886-015-0671-z.

Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Author information

1
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. luca.miele@rm.unicatt.it.
2
Clinical Division of Internal Medicine, Gastroenterology and Liver Unit, Complesso Integrato Columbus Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. luca.miele@rm.unicatt.it.
3
Pediatric Department, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. valentina.giorgio@rm.unicatt.it.
4
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. mariadele.alberelli@gmail.com.
5
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. edecandia@rm.unicatt.it.
6
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. agasbarrini@rm.unicatt.it.
7
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy. agrieco@rm.unicatt.it.

Abstract

Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.

KEYWORDS:

Cardiovascular disease; Gut microbiota; Obesity; Platelets; Type 2 diabetes

PMID:
26497040
DOI:
10.1007/s11886-015-0671-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center